Assignee
Nabriva Therapeutics GmbH
AT·2 granted patents·12 pending applications·1 citations·filing 2016–2024
Top patents by PatentIndex Score
14 records- 0173US2022218713A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2022·Application pending·0 cites
- 0271US10913703B2Purification of pleuromutilinNabriva Therapeutics GmbH·Filed 2018·Granted Feb 9, 2021·1 cites·20 claims
- 0370US2021113571A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0468US2020281933A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0565US2025009885A1Injectable pharmaceutical formulations of lefamulinNabriva Therapeutics GmbH·Filed 2024·Application pending·0 cites
- 0664US2020030335A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 0763US2019175603A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 0861US2018303842A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2018·Application pending·0 cites
- 0950US12121582B2Injectable pharmaceutical formulations of lefamulinNabriva Therapeutics GmbH·Filed 2016·Granted Oct 22, 2024·0 cites·17 claims
- 1050US2024208989A1Novel 12-epi-mutilin compounds and uses thereofNabriva Therapeutics GmbH·Filed 2022·Application pending·0 cites
- 1147US2025134844A1Therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2023·Application pending·0 cites
- 1244US2023218558A1Novel therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2021·Application pending·0 cites
- 1342US2023174509A1Therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2021·Application pending·0 cites
- 1441US2023174472A1Therapeutic use of pleuromutilinsNabriva Therapeutics GmbH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nabriva Therapeutics GmbH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →